Sirt6-mediated Nrf2/HO-1 activation alleviates angiotensin II-induced DNA DSBs and apoptosis in podocytes
Related Experiment Video
Updated: Oct 29, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Yanqin Fan1, Jing Cheng, Qian Yang
1Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. ghxding@gmail.com.
Abstract:
Recent studies suggested that DNA double-strand breaks (DSBs) were associated with the pathogenesis of chronic kidney disease (CKD). The purpose of this investigation was to determine the role of Sirtuin6 (Sirt6), a histone deacetylase related to DNA damage repair, in angiotensin (Ang) II-induced DNA DSBs and the cell injury of podocytes and explore the possible mechanism. Here we showed that an increase of DNA DSBs was accompanied by a reduction in Sirt6 expression in the glomeruli of patients with hypertensive nephropathy (HN). Similar results were found in rat kidneys infused with Ang II and in cultured podocytes stimulated with Ang II. Sirt6 overexpression inhibited Ang II-induced ROS generation and DNA DSBs, and thus served as a protection against Ang II-induced apoptosis in podocytes. Moreover, Sirt6 activation enhanced Nrf2 and HO-1 gene expressions in podocytes after Ang II treatment. Furthermore, Nrf2 knockdown could partly reverse the cytoprotective effects of Sirt6 activation. In conclusion, our observations demonstrated that the Sirt6-Nrf2-HO-1 pathway played a vital role in relieving Ang II-mediated oxidative DNA damage and podocyte injury.
Insights
Sirtuin6 (Sirt6) protects against kidney damage by reducing DNA double-strand breaks (DSBs) and cell injury in podocytes. The Sirt6-Nrf2-HO-1 pathway is key to this protective mechanism against angiotensin II-induced harm.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- DNA double-strand breaks (DSBs) are implicated in chronic kidney disease (CKD) pathogenesis.
- Sirtuin6 (Sirt6) is a histone deacetylase involved in DNA damage repair.
Purpose of the Study:
- To investigate Sirtuin6's role in angiotensin II-induced DNA DSBs and podocyte injury.
- To elucidate the underlying mechanism involving Sirt6 in kidney disease.
Main Methods:
- Assessed Sirt6 expression in human hypertensive nephropathy (HN) glomeruli.
- Utilized angiotensin II infusion in rats and cultured podocytes.
- Investigated the effects of Sirt6 overexpression and Nrf2 knockdown.
Main Results:
- Reduced Sirt6 expression correlated with increased DSBs in HN patients, Ang II-infused rats, and podocytes.
- Sirt6 overexpression mitigated Ang II-induced reactive oxygen species (ROS), DSBs, and apoptosis in podocytes.
- Sirt6 activation upregulated Nrf2 and HO-1 expression, with Nrf2 knockdown partially reversing protective effects.
Conclusions:
- The Sirt6-Nrf2-HO-1 pathway is crucial for mitigating angiotensin II-mediated oxidative DNA damage.
- Sirt6 activation protects podocytes from injury, suggesting a therapeutic target for kidney disease.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
DNA Damage can Stall the Cell Cycle

